McKesson / Bupa Home Healthcare merger inquiry

The CMA investigated the anticipated acquisition by McKesson Corporation of Bupa Home Healthcare Limited and Bupa Home Healthcare Group Limited.

Statutory timetable

Phase 1 date Action
17 August 2016 Decision published
28 June 2016 Decision announced
29 April to 16 May 2016 Invitation to comment
29 April 2016 Launch of merger inquiry

Phase 1

CMA clearance decision

28 June 2016: The CMA has cleared the anticipated acquisition by McKesson Corporation of Bupa Home Healthcare Limited and Bupa Home Healthcare Group Limited. The full text of the decision is available below.

Invitation to comment: Now closed

29 April 2016: The CMA is considering whether it is or may be the case that this transaction has resulted in the creation of a relevant merger situation under the merger provisions of the Enterprise Act 2002 and, if so, whether the creation of that situation has resulted, or may be expected to result, in a substantial lessening of competition within any market or markets in the United Kingdom for goods or services.

Launch of merger inquiry

29 April 2016: The CMA has launched its phase 1 investigation following the European Commission’s decision to refer the case to the United Kingdom under Article 4(4) of the EC Merger Regulation.

Contact

Please send written representations about any competition issues to:

Ronan Scanlan
Competition and Markets Authority
Victoria House
Southampton Row
London
WC1B 4AD

ronan.scanlan@cma.gsi.gov.uk

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.